HERTSFORDSHIRE, England and
PITTSBURGH, May 12, 2015 /PRNewswire/ -- Mylan N.V.
(Nasdaq: MYL) today announced that the Company will present at the
UBS Global Healthcare Conference on Monday
May 18, 2015. The presentation is scheduled to begin at
9:30 a.m. ET.
Interested parties can access a live webcast of the presentation
via the investor relations section of Mylan's Web site at
http://mylan.com/investors. An archived version will also be
available following the live presentation and can be accessed at
the same location for a limited time.
Mylan is a global pharmaceutical company committed to setting
new standards in healthcare. Working together around the world to
provide 7 billion people access to high quality medicine, we
innovate to satisfy unmet needs; make reliability and service
excellence a habit; do what's right, not what's easy; and impact
the future through passionate global leadership. We offer a growing
portfolio of around 1,400 generic pharmaceuticals and several brand
medications. In addition, we offer a wide range of antiretroviral
therapies, upon which approximately 40% of HIV/AIDS patients in
developing countries depend. We also operate one of the largest
active pharmaceutical ingredient manufacturers and currently market
products in about 145 countries and territories. Our workforce of
approximately 30,000 people is dedicated to creating better health
for a better world, one person at a time. Learn more at
mylan.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/mylan-to-present-at-the-ubs-global-healthcare-conference-300081633.html
SOURCE Mylan N.V.